Helicobacter pylori Reinfection after Apparent Eradication—The Ipswich Experience

References

• Penston J G. Helicobacter pylori eradication: understandable caution but no excuse for inertia. Aliment Pharmacol Ther 1994; 8: 369–89
   PubMed Web of Science ®Google Scholar
• Tytgat G NJ. Treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994; 8: 359–68
   PubMed Web of Science ®Google Scholar
• Rokkas T, Karameris A, Mavrogeogis A, Rallis E, Giannikos N. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc 1995; 41: 1–4
   PubMed Web of Science ®Google Scholar
• Jaspersen D, Koerner T, Schorr W, Brennenstuhl M, Raschka C, Hammar C H. Helicobacter pylori eradication reduces the risk of rebleeding in ulcer haemorrhage. Gastrointest Endosc 1995; 41: 5–7
   PubMed Web of Science ®Google Scholar
• Laine L. The long-term management of patients with bleeding ulcers: Helicobacter pylori eradication instead of maintenance antisecretory therapy. Gastrointest Endosc 1995; 41: 77–9
   PubMedGoogle Scholar
• Bell G D, Powell K U, Bolton G, Richardson P DI. Clinical and pharmacoeconomic evaluation strategies for duodenal ulcer disease. Br J Med Econ 1993; 6: 45–58
   Google Scholar
• Powell K U, Bell G D, Bolton G H, Burridge S M, Bowden A F, Rameh B, et al. Helicobacter pylori eradication in patients with peptic ulcer disease: clinical consequences and financial implications. Q J Med 1994; 87: 283–90
   PubMedGoogle Scholar
• Powell K U, Youngman P R, Bell G D, Burridge S M, Hastings L. A general practice study of Helicobacter pylori eradication treatment in patients using long-term ulcer-healing therapy. Br J Clin Res 1995; 6: 21–9
   Google Scholar
• Bell G D, Powell K U, Burridge S M, Spencer G M, Weil J, Gant P W, et al. 'Reinfection' after apparently successful eradication of Helicobacter pylori infection. Q J Med 1993; 86: 375–82
   PubMedGoogle Scholar
• Bell G D, Powell K U, Bowden A, Harrison G, Trowell J E, Jones P H. Treatment of Helicobacter pylori infection—relationship between initial eradication rate and the observed 'reinfection' rate six months post treatment. Gut 1994; 35(Suppl 5)S2
   Google Scholar
• Yamada T, Ahnen D, Alpers D H, Greenberg H B, Gray L, Joscelyn K B, et al. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65–9
   PubMed Web of Science ®Google Scholar
• Bell G D, Weil J, Harrison G, Morden A, Jones P H, Gant P W, et al. 14C-urea breath analysis, a non-invasive test for Campylobacter pylori in the stomach. Lancet 1987; 1: 1367–8
   PubMed Web of Science ®Google Scholar
• Bell G D, Weil J. Detection of Helicobacter pylori by the 14C-urea breath test. Helicobacter pylori and gastroduodenal disease, B J Rathbone, R V Heatley. Blackwell Scientific Publications, Oxford 1992; 74–87
   Google Scholar
• Weil J, Bell G D, Jones P H, Gant P, Trowell J E, Harrison G. 'Eradication' of Campylobacter pylori: are we being misled?. Lancet 1988; 2: 1245
   PubMedGoogle Scholar
• Bell G D. Anti-Helicobacter pylori therapy: clearance, elimination or eradication?. Lancet 1991; 337: 311
   Google Scholar
• Weil J, Bell G D, Harrison G, Trowell J, Gant P, Jones P H. Campylobacter pylori survives high dose bismuth subcitrate (De-Nol) therapy. Gut 1988; 29: A1437–8
   Google Scholar
• Weil J, Bell G D, Powell K, Morden A, Harrison G, Gant P W, et al. Helicobacter pylori: treatment with combinations of pivampicillin and tripotassium dicitrato bismuthate. Aliment Pharmacol Ther 1991; 5: 543–7
   PubMedGoogle Scholar
• Weil J, Bell G D, Powell K, Morden A, Harrison G, Gant P W, et al. Omeprazole and Helicobacter pylori: temporary suppression rather than true eradication. Aliment Pharmacol Ther 1991; 5: 309–13
   PubMed Web of Science ®Google Scholar
• Weil J, Bell G D, Powell K, Morden A, Harrison G, Gant P W, et al. Helicobacter pylori infection treated with a tripotassium dicitrato bismuth and metronidazole combination. Aliment Pharmacol Ther 1990; 4: 651–7
   PubMed Web of Science ®Google Scholar
• Bell G D, Weil J, Powell K, Jobson R, Harrison G, Gant P W, et al. Helicobacter pylori treated with combinations of tripotassium dicitrato bismuthate and metronidazole: efficacy of different treatment regimens and some observations on the emergence of metronidazole resistance. Eur J Gastroenterol Hepatol 1991; 3: 819–22
   Web of Science ®Google Scholar
• Bell G D, Powell K, Burridge S M, Pallecaros A, Jones P H, Gant P W, et al. Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther 1992; 6: 427–35
   PubMed Web of Science ®Google Scholar
• Bell G D, Powell K U, Burridge S M, Spencer G, Bolton G, Purser K, et al. Short report: omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori. Aliment Pharmacol Ther 1992; 6: 751–8
   PubMed Web of Science ®Google Scholar
• Bell G D, Powell K U, Burridge S M, Bowden A N, Rameh B, Bolton G, et al. Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with 3 different forms of bismuth containing triple therapy. Q J Med 1993; 86: 743–50
   PubMedGoogle Scholar
• Bell G D, Bate C M, Axon A TR, Tildesley G, Green J RB, Emmas C E, et al. Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication in a double-blind randomised trial. Aliment Pharmacol Ther 1995; 9: 513–20
   PubMed Web of Science ®Google Scholar
• Bell G D, Powell K U, Burridge S M, Bowden A F, Atoyebi W, Bolton G H, et al. Rapid eradication of Helicobacter pylori in ulcer disease. Aliment Pharmacol Ther 1995; 9: 41–6
   PubMed Web of Science ®Google Scholar
• Powell K U, Bell G D, Bowden A, Trowell J E, Jones P H. One week Helicobacter pylori eradication therapy with omeprazole, clarithromycin and metronidazole is as effective as two week therapy. Br J Clin Res 1995; 6: 85–90
   Google Scholar
• Hentschel E, Brandstätter G, Dragosics B, Hirschl A M, Nemec H, Schutze K, et al. Effect of ranitidine and amoxycillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328: 308–12
   PubMed Web of Science ®Google Scholar
• Powell K U, Bell G D, Bowden A F, Trowell J E, Jones P H. Helicobacter pylori eradication therapy: a comparison between either omeprazole or ranitidine in combination with amoxycillin plus metronidazole. Br J Clin Res 1995; 6: 163–9
   Google Scholar
• Xia H X, Marshall D G, Windle H J, Smyth C J, Keane C T, O'Morain C A. Reinfection or recrudescence of Helicobacter pylori infection. Gut 1994; 35(Suppl 2)S3
   Google Scholar
• de Boer W, Driessen W, Jansz A, Tytgat G. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995; 345: 817–20
   PubMed Web of Science ®Google Scholar
• Goddard A, Logan R. One week low-dose triple therapy: new standards for Helicobacter pylori treatment. Eur J Gastroenterol Hepatol 1995; 7: 1–3
   PubMed Web of Science ®Google Scholar
• Banatvala N, Davies G R, Abdi Y, Clements L, Rampton D S, Hardie J M, et al. High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease. Gut 1994; 35: 1562–6
   PubMed Web of Science ®Google Scholar
• Louw J A, Lucke W, Jaskiewicz K, Lastovica A J, Winter T A, Marks I N. Helicobacter pylori eradication in the African setting, with special reference to reinfection and duodenal ulcer recurrence. Gut 1995; 36: 544–7
   PubMedGoogle Scholar
• Coelho L GU, Passos M CF, Chausson Y, Sola L M, Maia A F, Brandao M JCC, et al. Duodenal ulcer and eradication of Helicobacter pylori in a developing country. Scand J Gastroenterol 1992; 27: 363–6
   Web of Science ®Google Scholar